CIK 0001818794
- Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364883909
- Phone
- +1 781-786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Medical Officer acquired 50,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Conversion 10% owner acquired 4,951,303 shares (conversion)
- 4 Open-market buy 10% owner bought 815,000 shares at $19.00 ($15,485,000)
- 4 Conversion Director acquired 53,625 shares (conversion)
- 4 Open-market buy 10% owner bought 700,000 shares at $19.00 ($13,300,000)
- 4 Conversion 10% owner acquired 6,131,079 shares (conversion)
- 4 Conversion 10% owner acquired 602,972 shares (conversion)
- 4 Conversion Director acquired 10,725 shares (conversion)
- 4 Conversion Director acquired 10,725 shares (conversion)
- 4 Conversion Director acquired 7,638,511 shares (conversion)
- 4 Conversion Director acquired 6,131,079 shares (conversion)
- 4 Conversion 10% owner acquired 1,608,785 shares (conversion)
- 4 Conversion 10% owner acquired 7,638,511 shares (conversion)
- 4 Open-market buy 10% owner bought 660,000 shares at $19.00 ($12,540,000)
- 4 Conversion Director acquired 4,951,303 shares (conversion)
- 4 Grant or award Chief Operating Officer acquired 35,904 shares (grant or award)
Page 17 of 19 · 365 filings